Control of furunculosis by antimicrobial chemotherapy

<i>In vitro</i> ativities of six fluoroquinolone antimicrobials, flumequine, sarafloxacin, PD127,391, PD117,596, enrofloxacin and Ro 09-1690, against <i>Aeromonas salmonicida</i>, isolated from outbreaks of furunculosis in farmed and wild Atlantic salmon (<i>salmo salar...

Full description

Bibliographic Details
Main Author: Barnes, Andrew C.
Published: University of Edinburgh 1993
Subjects:
615
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.641322
id ndltd-bl.uk-oai-ethos.bl.uk-641322
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-6413222017-04-20T03:20:23ZControl of furunculosis by antimicrobial chemotherapyBarnes, Andrew C.1993<i>In vitro</i> ativities of six fluoroquinolone antimicrobials, flumequine, sarafloxacin, PD127,391, PD117,596, enrofloxacin and Ro 09-1690, against <i>Aeromonas salmonicida</i>, isolated from outbreaks of furunculosis in farmed and wild Atlantic salmon (<i>salmo salar</i>), were evaluated in terms of minimum inhibitory concentration (MIC), bactericidal activity and the frequency at which mutation to resistance developed to the drugs compared to oxolinic acid, the 4-quinolone antibiotic currently licensed for furunculosis therapy in the UK. MICs were also determined for oxytetracycline and the β-lactam amoxycillin. In terms of MIC, the fluoroquinolones were more active than oxolinic acid with MICs reduced from 2- to 500-fold. Furthermore, the fluoroquinolones were bactericidal against both oxolinic acid-resistant and -susceptible isolates of <i>A.salmonicida</i> whereas oxolinic acid was not bactericidal against any bacteria tested. In addition to the increased antimicrobial activity, the frequency at which <i>A.salmonicida</i> mutated to resistance to the fluoroquinolones was lower than the frequency for resistance to oxolinic acid. Amoxycillin was active against all the <i>A.salmonicida</i> subsp. <i>salmonicida</i> isolates tested; however, the atypical <i>A.salmonicida</i> subsp. <i>achromogenes</i> isolates were resistant to amoxycillin with MICs in excess of 500mg/l. Ion effects were noted for the quinolones and oxytetracycline. For instance, the presence of 50mM MgCl_2 resulted in a 20- to 60- fold increase in the MICs of these drugs against the test strains. No ion effect was identified for amoxycillin. The quinolones were not affected by inoculum size but their efficacy, in terms of MIC, was reduced at the lower temperature of 10°C compared to 22°C. Mechanisms of resistance to the fluoroquinolones, oxytetracycline and amoxycillin were investigated. Low levels of resistance to the quinolones and oxytetracycline could be induced with either oxolinic acid or oxytetracycline, with each drug inducing cross resistance to the other. This phenomenon was discovered to result from alterations in outer membrane proteins, specifically the increase in expression of a 42kDa and a decrease in expression of a 37kDa protein.615University of Edinburghhttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.641322http://hdl.handle.net/1842/19915Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 615
spellingShingle 615
Barnes, Andrew C.
Control of furunculosis by antimicrobial chemotherapy
description <i>In vitro</i> ativities of six fluoroquinolone antimicrobials, flumequine, sarafloxacin, PD127,391, PD117,596, enrofloxacin and Ro 09-1690, against <i>Aeromonas salmonicida</i>, isolated from outbreaks of furunculosis in farmed and wild Atlantic salmon (<i>salmo salar</i>), were evaluated in terms of minimum inhibitory concentration (MIC), bactericidal activity and the frequency at which mutation to resistance developed to the drugs compared to oxolinic acid, the 4-quinolone antibiotic currently licensed for furunculosis therapy in the UK. MICs were also determined for oxytetracycline and the β-lactam amoxycillin. In terms of MIC, the fluoroquinolones were more active than oxolinic acid with MICs reduced from 2- to 500-fold. Furthermore, the fluoroquinolones were bactericidal against both oxolinic acid-resistant and -susceptible isolates of <i>A.salmonicida</i> whereas oxolinic acid was not bactericidal against any bacteria tested. In addition to the increased antimicrobial activity, the frequency at which <i>A.salmonicida</i> mutated to resistance to the fluoroquinolones was lower than the frequency for resistance to oxolinic acid. Amoxycillin was active against all the <i>A.salmonicida</i> subsp. <i>salmonicida</i> isolates tested; however, the atypical <i>A.salmonicida</i> subsp. <i>achromogenes</i> isolates were resistant to amoxycillin with MICs in excess of 500mg/l. Ion effects were noted for the quinolones and oxytetracycline. For instance, the presence of 50mM MgCl_2 resulted in a 20- to 60- fold increase in the MICs of these drugs against the test strains. No ion effect was identified for amoxycillin. The quinolones were not affected by inoculum size but their efficacy, in terms of MIC, was reduced at the lower temperature of 10°C compared to 22°C. Mechanisms of resistance to the fluoroquinolones, oxytetracycline and amoxycillin were investigated. Low levels of resistance to the quinolones and oxytetracycline could be induced with either oxolinic acid or oxytetracycline, with each drug inducing cross resistance to the other. This phenomenon was discovered to result from alterations in outer membrane proteins, specifically the increase in expression of a 42kDa and a decrease in expression of a 37kDa protein.
author Barnes, Andrew C.
author_facet Barnes, Andrew C.
author_sort Barnes, Andrew C.
title Control of furunculosis by antimicrobial chemotherapy
title_short Control of furunculosis by antimicrobial chemotherapy
title_full Control of furunculosis by antimicrobial chemotherapy
title_fullStr Control of furunculosis by antimicrobial chemotherapy
title_full_unstemmed Control of furunculosis by antimicrobial chemotherapy
title_sort control of furunculosis by antimicrobial chemotherapy
publisher University of Edinburgh
publishDate 1993
url http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.641322
work_keys_str_mv AT barnesandrewc controloffurunculosisbyantimicrobialchemotherapy
_version_ 1718440029448044544